The epidemiology of invasive group A streptococcal disease in Victoria, Australia
- PMID: 17547544
- DOI: 10.5694/j.1326-5377.2007.tb01054.x
The epidemiology of invasive group A streptococcal disease in Victoria, Australia
Abstract
Objective: To estimate the incidence and severity of invasive group A streptococcal infection in Victoria, Australia.
Design: Prospective active surveillance study.
Setting: Public and private laboratories, hospitals and general practitioners throughout Victoria.
Patients: People in Victoria diagnosed with group A streptococcal disease notified to the surveillance system between 1 March 2002 and 31 August 2004.
Main outcome measure: Confirmed invasive group A streptococcal disease.
Results: We identified 333 confirmed cases: an average annual incidence rate of 2.7 (95% CI, 2.3-3.2) per 100,000 population per year. Rates were highest in people aged 65 years and older and those younger than 5 years. The case-fatality rate was 7.8%. Streptococcal toxic shock syndrome occurred in 48 patients (14.4%), with a case-fatality rate of 23%. Thirty cases of necrotising fasciitis were reported; five (17%) of these patients died. Type 1 (23%) was the most frequently identified emm sequence type in all age groups. All tested isolates were susceptible to penicillin and clindamycin. Two isolates (4%) were resistant to erythromycin.
Conclusion: The incidence of invasive group A streptococcal disease in temperate Australia is greater than previously appreciated and warrants greater public health attention, including its designation as a notifiable disease.
Similar articles
-
Epidemiology of invasive Streptococcus pyogenes infections in France in 2007.J Clin Microbiol. 2011 Dec;49(12):4094-100. doi: 10.1128/JCM.00070-11. Epub 2011 Oct 5. J Clin Microbiol. 2011. PMID: 21976764 Free PMC article.
-
Invasive Group A streptococcal disease in Ireland, 2004 to 2010.Euro Surveill. 2011 Oct 13;16(41):19988. Euro Surveill. 2011. PMID: 22008200
-
Effectiveness of clindamycin and intravenous immunoglobulin, and risk of disease in contacts, in invasive group a streptococcal infections.Clin Infect Dis. 2014 Aug 1;59(3):358-65. doi: 10.1093/cid/ciu304. Epub 2014 Apr 29. Clin Infect Dis. 2014. PMID: 24785239
-
Epidemiologic features of invasive group A Streptococcus infection in a rural hospital: 6-year retrospective report and literature review.Can J Rural Med. 2017 Fall;22(4):131-138. Can J Rural Med. 2017. PMID: 28925912 Review.
-
[Beta-hemolytic streptococcal bacteremia in adults].Duodecim. 2013;129(14):1477-84. Duodecim. 2013. PMID: 23961606 Review. Finnish.
Cited by
-
Streptococcus pyogenes emm98.1 variants activate inflammatory caspases in human neutrophils.Virulence. 2023 Dec;14(1):2264090. doi: 10.1080/21505594.2023.2264090. Epub 2023 Oct 13. Virulence. 2023. PMID: 37830540 Free PMC article.
-
A Glycolipidated-liposomal peptide vaccine confers long-term mucosal protection against Streptococcus pyogenes via IL-17, macrophages and neutrophils.Nat Commun. 2023 Sep 25;14(1):5963. doi: 10.1038/s41467-023-41410-7. Nat Commun. 2023. PMID: 37749129 Free PMC article.
-
Current scenario of recently rising up cases of invasive group A streptococcal (iGAS) infections in younger children in many European nations: clinical management and prospective counteracting measures - an update.Int J Surg. 2023 Mar 1;109(3):579-581. doi: 10.1097/JS9.0000000000000156. Int J Surg. 2023. PMID: 36906758 Free PMC article. No abstract available.
-
Standardization of Epidemiological Surveillance of Group A Streptococcal Cellulitis.Open Forum Infect Dis. 2022 Sep 15;9(Suppl 1):S25-S30. doi: 10.1093/ofid/ofac267. eCollection 2022 Sep. Open Forum Infect Dis. 2022. PMID: 36128406 Free PMC article.
-
Invasive Group A Streptococcus Outbreaks Associated with Home Healthcare, England, 2018-2019.Emerg Infect Dis. 2022 May;28(5):915-23. doi: 10.3201/eid2805.211497. Emerg Infect Dis. 2022. PMID: 35451366 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical